We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamuel Heath Regulatory News (HSM)

Share Price Information for Samuel Heath (HSM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 275.00
Bid: 250.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 50.00 (20.00%)
Open: 275.00
High: 275.00
Low: 275.00
Prev. Close: 275.00
HSM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

12 Nov 2020 07:00

RNS Number : 0488F
Heath(Samuel) & Sons PLC
12 November 2020
 

SAMUEL HEATH & SONS plc

("the Company")

 

INTERIM REPORT

 

Half year ended 30 September 2020

 

CHAIRMAN'S STATEMENT

 

 

This has been the most extraordinary half year in my rather lengthy business career. Regrettably there is still not yet a clear outcome by any means.

 

Our trading performance for the six months until September 30th was quite a lot better than feared but still only produced a small profit of £6k before exceptional items (2019: £363k), on sales of £4.850m (2019: £6.920m). As I mentioned in my annual report, without any doubt this was greatly aided by the Government's furlough scheme. This was imaginative and effective. It helped us on all sides of the business, but particularly on the sales side. However, as it was coming to an end, we had to make some difficult decisions to protect the future of the Company. This resulted in considerable redundancy payments, shown in the accounts as exceptional. This brought our total half year results to a loss of £224k before taxation (2019: profit £363k).

 

You cannot run a business like ours successfully for long without a considerable sales team, focussed marketing activities and continual research and development. We have therefore brought these back into play for the second half of the year. This is clearly not without risk.

 

There are differing views on the next six months. We have the U.S. election which could affect a manufacturer at the luxury end of the market, the unknown outcome of the talks with the EU, and, by far the worst of all, the return in volume of the Coronavirus. Anybody offering a forecast in these circumstances would be extremely unwise.

 

This leaves the question of the dividend. Apart from the ethical question of whether we should pay out dividends when in receipt of Government money, notwithstanding the millions we have paid over the years in taxes, there is more importantly the possible cash requirements of the Company over the next six months. We have therefore decided not to pay an interim dividend but hope to return to normality next year.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Sam Heath

Chairman

11 November 2020

 

For further information, please contact:

Samuel Heath & Sons Plc

Simon Latham, Company Secretary 0121 766 4200

 

Cairn Financial Advisers LLP

James Caithie / Jo Turner 020 7213 0880

 

Unaudited Interim Financial Report

For the Half Year ended 30 September 2020

 

CONSOLIDATED INCOME STATEMENT

 

 

 

 

 

 

Half year

 

Half year

 

Year

 

ended 30

 

ended 30

 

ended 31

 

September

 

September

 

March

 

2020

 

2019

 

2020

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

Revenue

4,850

 

6,920

 

13,887

 

 

 

 

 

 

Cost of sales

(3,062)

 

(3,598)

 

(6,798)

 

 

 

 

 

 

Gross profit

1,788

 

3,322

 

7,089

 

 

 

 

 

 

Selling and distribution costs

(1,344)

 

(1,776)

 

(3,543)

Administrative expenses

(940)

 

(1,067)

 

(2,012)

Other operating income - grant (note 6)

596

 

-

 

-

 

 

 

 

 

 

Operating profit

100

 

479

 

1,534

 

 

 

 

 

 

Finance income

14

 

 9

 

25

Finance cost

(108)

 

(125)

 

(191)

 

 

 

 

 

 

 

 

 

 

 

 

Profit before taxation and exceptional items

 

6

 

363

 

1,368

 

 

 

 

 

 

Exceptional item (note 5)

(230)

 

-

 

-

 

 

 

 

 

 

(Loss)/profit before taxation

(224)

 

363

 

1,368

 

 

 

 

 

 

Taxation

43

 

(69)

 

(299)

 

 

 

 

 

 

(Loss)/profit for the period

(181)

 

294

 

1,069

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted (loss)/earnings per ordinary share (note 4)

(7.1p)

 

11.6p

 

42.2p

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

 

 

 

 

Half year ended 30 September

 

Half year ended 30 September

 

Year ended 31 March

 

 

2020

 

2019

 

2020

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

(Loss)/profit for the period

(181) 

 

294

 

1,069

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Items that will not be reclassified to profit or loss:

 

 

 

 

 

Actuarial gain/(loss) on defined benefit pension scheme

(1,239)

 

 204

 

291

Deferred tax on actuarial loss/(gain)

218

 

(34)

 

(55)

Deferred tax rate change

-

 

-

 

125

Revaluation of property, plant and equipment

-

 

-

 

182

Deferred taxation on revaluation of assets

-

 

-

 

(23)

 

 

 

 

 

 

 

(1,021)

 

170

 

520

 

 

 

 

 

 

Total comprehensive income for the period

(1,202)

 

464

 

1,589

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

At 30 September

 

 At 30 September

 

At 31 March

 

 

2020

 

2019

 

2020

 

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

Non-current assets

 

 

 

 

 

Intangible assets

135

 

74

 

151

Property, plant and equipment

3,541

 

3,519

 

3,635

Deferred tax assets

1,103

 

972

 

887

 

 

 

 

 

 

 

4,779

 

4,565

 

4,673

 

 

 

 

 

 

Current assets

 

 

 

 

 

Inventories

3,869

 

3,883

 

4,230

Trade and other receivables

1,689

 

2,216

 

2,370

Cash and cash equivalents

3,424

 

3,100

 

3,016

 

8,982

 

9,199

 

9,616

 

 

 

 

 

 

Total assets

13,761

 

13,764

 

14,289

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Trade and other payables

(1,772)

 

(1,665)

 

(1,868)

Right of use lease liabilities

(53)

 

(57)

 

(58)

Current tax payable

(36)

 

(239)

 

(79)

 

(1,861)

 

(1,961)

 

(2,005)

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

Right of use lease liabilities

(26)

 

(75)

 

(46)

Retirement benefit scheme

(7,413)

 

(7,050)

 

(6,575)

 

(7,439)

 

(7,125)

 

(6,621)

 

 

 

 

 

 

Total liabilities

(9,300)

 

(9,086)

 

(8,626)

 

 

 

 

 

 

Net assets

4,461

 

4,678

 

5,663

 

 

 

 

 

 

Equity

 

 

 

 

 

Called up share capital

254

 

254

 

254

Capital redemption reserve

109

 

109

 

109

Revaluation reserve

Retained earnings

1,308

2,790

 

1,224

3,091

 

1,349

3,951

 

 

 

 

 

 

Equity shareholders' funds

4,461

 

4,678

 

5,663

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

       

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

 

 

Share capital

Capital redemption reserve

Revaluation reserve

Retained earnings

Total equity

 

£000

£000

£000

£000

£000

 

 

 

 

 

 

Balance at 31 March 2019

254

109

1,277

2,748

4,388

 

Total transactions with owners

 

 

 

 

 

Equity dividends paid

-

-

-

(174)

 (174)

 

 

 

 

 

 

Profit for the period

-

-

-

294

294

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

-

 

(53)

170

 

53

170

 

-

Total comprehensive income for the period

-

-

(53)

517

464

 

 

 

 

 

 

Balance at 30 September 2019

254

109

1,224

3,091

4,678

 

Total transactions with owners

 

 

 

 

 

Equity dividends paid

-

-

-

(140)

(140)

 

 

 

 

 

 

Profit for the period

-

-

-

775

775

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

159

 

(34)

191

 

34

350

 

-

Total comprehensive income for the period

-

-

125

1,000

1,125

 

 

 

 

 

 

Balance at 31 March 2020

254

109

1,349

3,951

5,663

 

 

 

 

 

 

Total transactions with owners

Equity dividends paid

-

-

-

-

-

 

 

 

 

 

 

Loss for the period

-

-

-

(181)

(181)

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

-

 

(41)

(1,021)

 

41

(1,021)

 

-

Total comprehensive income for the period

-

-

(41)

(1,161)

(1,202)

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 September 2020

254

109

1,308

2,790

4,461

 

 

 

 

 

 

 

CONSOLIDATED CASH FLOW STATEMENT

 

 

Half year ended 30 September

 

Half year ended 30 September

 

Year ended 31 March

 

2020

 

2019

 

2020

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

Cash flow from operating activities

 

 

 

 

 

 

 

 

 

 

 

(Loss)/profit for the period before taxation

(224)

 

363

 

1,368

 

 

 

 

 

 

Adjustments for:

 

 

 

 

 

Depreciation

155

 

192

 

405

Amortisation

16

 

8

 

16

Loss/(profit) on disposal of property, plant and equipment

-

 

3

 

(3)

Net finance cost/(income)

(14)

 

7

 

(25)

Defined benefit pension scheme expenses

98

 

137

 

228

Contributions to defined benefit pension scheme

(500)

 

(266)

 

(783)

 

 

 

 

 

 

Operating cash flow before movements in working capital

(469)

 

444

 

1,206

 

 

 

 

 

 

Changes in working capital:

 

 

 

 

 

Decrease/(increase) in inventories

361

 

 106

 

(241)

Decrease/(increase) in trade and other receivables

658

 

46

 

(84)

(Decrease)/increase in trade and other payables

(65)

 

23

 

79

 

 

 

 

 

 

Cash generated from operations

485

 

619

 

960

 

 

 

 

 

 

Taxation paid

-

 

-

 

(180)

 

 

 

 

 

 

Net cash from operating activities

485

 

619

 

780

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

 

Payments to acquire property, plant and equipment

(61)

 

(510)

 

(502)

Proceeds from the sale of property, plant and equipment

-

 

19

 

14

Payments to acquire intangible assets

-

 

-

 

(85)

Net finance income

14

 

(5)

 

25

 

 

 

 

 

 

 

(47)

 

(496)

 

(548)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

 

Payment for right of use assets

(30)

 

(2)

 

(55)

Dividends paid

-

 

(174)

 

(314)

 

 

 

 

 

 

 

(30)

 

(176)

 

(369)

 

 

 

 

 

 

 

 

 

 

 

 

Net increase in cash and cash equivalents

408

 

(53)

 

(137) 

Cash and cash equivalents at beginning of period

3,016

 

3,153

 

3,153

 

 

 

 

 

 

Cash and cash equivalents at end of period

3,424

 

3,100

 

3,016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTES TO THE INTERIM FINANCIAL REPORT

 

 

1. BASIS OF PREPARATION OF INTERIM REPORT

As permitted, IAS34 'Interim Financial Reporting' has not been applied in this interim report. The information for the period ended 30 September 2020 is not audited and does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The statutory accounts for the year ended 31 March 2020 were given an unqualified audit report and did not contain statements under section 498(2) or 498(3) of the Companies Act 2006. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies. The interim accounts for the half year ended 30 September 2019 were also unaudited.

2. ACCOUNTING POLICIES

Basis of accounting

The report has been prepared on a going concern basis in accordance with International Financial Reporting Standards and interpretations issued by the International Financial Reporting Interpretations Committee as adopted by the European Union.

 

The group has not availed itself of early adoption options in standards and interpretations.

 

The principal accounting policies adopted are as set out in the Annual Report for the year ended 31 March 2020. The valuation of inventories is considered to be the main area in terms of significant accounting estimates and judgements.

The retirement benefit scheme liability recognised in these interim accounts reflects the estimated change in the deficit at 30 September 2020 from the movements in discount rates and inflation during the six months.

3. DIVIDENDS

 

No Interim dividend is proposed (paid 20 March 2020: 5.5p).

4. (LOSS)/EARNINGS PER SHARE 

The basic and diluted (loss)/earnings per share are calculated by dividing the relevant loss after taxation of £181,000 (30 September 2019: profit £294,000) by the average number of ordinary shares in issue during the period being 2,534,322 (2019: 2,534,322). The number of shares used in the calculation is the same for both basic and diluted earnings.

5. EXCEPTIONAL ITEM

The exceptional item for the 6 months to 30 September 2020 relates to restructuring costs within the business.

6. OTHER OPERATING INCOME - GRANT FUNDING

Income has been received from government grants providing support during the Coronavirus pandemic:

JRS £571,000

Borough Hammersmith & Fulham £ 25,000

 

Income has been accounted for under the accruals method.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BIBDBLDBDGGB
Date   Source Headline
21st Nov 20237:00 amRNSHalf-year Report
7th Sep 20231:53 pmRNSResult of AGM
21st Jul 20237:00 amRNSFinal Results
9th Dec 20221:48 pmRNSHolding(s) in Company
9th Dec 20221:45 pmRNSDirector/PDMR Shareholding
18th Nov 20227:00 amRNSHalf-year Report
25th Aug 20223:08 pmRNSResult of AGM
20th Jul 202212:40 pmRNSReplacement: Final Results
20th Jul 20227:00 amRNSFinal Results
12th Nov 20217:00 amRNSHalf-year Report
6th Aug 20211:35 pmRNSResult of AGM
19th Jul 202110:14 amRNSDirectorate Change
8th Jul 20212:34 pmRNSFinal Results
30th Dec 20207:00 amRNSDirectorate Change
12th Nov 20207:00 amRNSHalf-year Report
7th Aug 20202:35 pmRNSResult of AGM
10th Jul 20207:30 amRNSFinal Results
9th Jul 20204:13 pmRNSHolding(s) in Company
8th Apr 20203:40 pmRNSCOVID-19 Trading Update
6th Feb 20207:00 amRNSDirectorate Change
18th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20199:53 amRNSDirectorate Change
15th Nov 20197:00 amRNSHalf-year Report
9th Aug 20192:45 pmRNSResult of AGM
15th Jul 20194:38 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSFinal Results
1st Apr 201911:47 amRNSPDMR/PCA Dealing
8th Nov 20187:00 amRNSHalf-year Report
10th Aug 20181:01 pmRNSResult of AGM
12th Jul 20183:26 pmRNSFinal Results
15th Jan 201811:13 amRNSDividend Record Date
9th Nov 20177:00 amRNSHalf-year Report
13th Oct 20179:45 amRNSHolding(s) in Company
13th Oct 20179:43 amRNSHolding(s) in Company
29th Sep 20177:00 amRNSDirectorate Change
1st Sep 20179:22 amRNSDirectorate Change
14th Aug 201711:48 amRNSResult of AGM
12th Jul 20179:33 amRNSFinal Results
16th Jun 20177:00 amRNSDirector/PDMR Shareholding - Replacement
10th May 20172:34 pmRNSDirector/PDMR Shareholding
7th Mar 20173:36 pmRNSDirector/PDMR Dealing
28th Feb 20177:00 amRNSDirectorate Change
16th Nov 20168:00 amRNSHalf-year Report
29th Sep 20163:59 pmRNSDirectorate Change
12th Aug 20161:26 pmRNSResult of AGM
11th Aug 201612:22 pmRNSDirectorate Change
13th Jul 20167:00 amRNSFinal Results
7th Jul 20162:32 pmRNSNotice of Results
6th May 20167:00 amRNSChange of Adviser
4th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.